Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The EPISTRESS2 study is a one-off cross-sectional epidemiological survey, carried out via an online form in patients with type 1 diabetes followed up by participating investigating centres.
In type 1 diabetes (T1DM), studies on stress and its impact on glycaemia have led to ambiguous results, mainly because there are no solid epidemiological or experimental data in the literature. The aim of this study was to assess the impact of perceived stress on blood glucose levels in a population of subjects with T1DM at 10 national centres.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| questionnaires | Other | filling in questionnaires |
| Measure | Description | Time Frame |
|---|---|---|
| The primary endpoint is the characterisation of 4 profiles of patients with type 1 diabetes on insulin pumps. | Questionnaire for Assessing the Impact of Stress on Blood Sugar Levels. This questionnaire was designed and developed by CERITD to assess the impact of perceived stress on blood glucose levels in T1DM patients. | 30 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Identify sub-populations of patients who feel stressed |
Questionnaire for Assessing the Impact of Stress on Blood Sugar Levels | 30 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
To study the impact of stress on glycaemia, we chose to conduct an epidemiological study in France on a population of type 1 diabetic patients (T1DM).
Many patients frequently and systematically cite stress as a frequent cause, or even the main cause, of the deterioration in their glycaemic control.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sylvia Franc, MD | Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Angers University Hospital | Angers | 49100 | France | |||
| Avignon Hospital |
Not provided
Not provided
Not provided
Not provided
| Establish and categorise the different stress factors | Cungi brief stress evaluation scales The Cungi 1 scale is composed of 8 items. This questionnaire assesses patient stressors. The maximum score is 48, the minimum score is 8. A high score reflects a large number of stressors The Cungi 2 scale is composed of 11 items. This questionnaire assesses the patient's sensitivity to stress. The maximum score is 66, the minimum score is 11. A high score reflects a high senstivity of stress. | 30 minutes |
| Establishing a relationship between personality type and the impact of stress | State-Trait Anxiety Inventory (STAI) questionnaire. The STAI-Y1 is composed of 20 items. This questionnaire assesses how the patient feels at the present moment. Patients are asked to score each question on a four-point scale (from 1 - corresponding to "not at all" to 4 - "much") The STAI-Y2 is composed of 20 items. This questionnaire assesses how the patient feels in general. Patients are asked to answer each question on a four-point scale (from 1 - corresponding to "almost never" to 4 - "almost always"). | 30 minutes |
| Evaluation of the quality of life score obtained according to the 4 profiles and/or personalities | EQ-5D-5L (European Quality of Life 5 Dimensions) questionnaire The EQ-5D-5L assesses five health dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension is rated on five levels of severity. The levels of severity for each dimension ranges from no problems (1) to extreme problems/unable to perform (5) | 30 minutes |
| Avignon |
| 84000 |
| France |
| St André Hospital | Bordeaux | 33076 | France |
| Brest University Hospital | Brest | 29200 | France |
| Dijon University Hospital | Dijon | 21079 | France |
| CERITD | Évry | 91058 | France |
| Grenoble University Hospital | Grenoble | 38043 | France |
| Lille University Hospital | Lille | 59037 | France |
| APHM- La Conception Hospital | Marseille | 13000 | France |
| Private practice in endocrinology and metabolic diseases | Mérignac | 33700 | France |
| Srasbourg University Hospital | Strasbourg | 67091 | France |
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D011795 | Surveys and Questionnaires |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
Not provided
Not provided